DARA BioSciences and America Stem Cell Broaden Collaboration
RALEIGH, N.C., Oct. 12, 2009 (GLOBE NEWSWIRE) — DARA BioSciences, Inc. (Nasdaq: DARA ), a development-stage biopharmaceutical company, announced today that the Company has entered into an Addendum and First Amendment to Material Transfer Agreement …
[Read the full article here]Related News:
NeoStem, Inc. and ImmuneRegen BioSciences Announce a Collaborative Agreement to Advance Stem Cell Technology
NeoStem, ImmuneRegen BioSciences Team to Develop Adult Human Stem Cell …
Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold …